Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Podcasts

OUTSPOKEN ONCOLOGY
05/03/2022
Ishwaria Subbiah, MD, MS, explains the value of having a dedicated team for oncology patient symptom management and demonstrates how using “supportive care” rather than “palliative care” can impact referrals.
Ishwaria Subbiah, MD, MS, explains the value of having a dedicated team for oncology patient symptom management and demonstrates how using “supportive care” rather than “palliative care” can impact referrals.
Ishwaria Subbiah, MD, MS,...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
At the Oncology Clinical Pathways Congress, Chadi sat down with a host of experts to discuss pathway integration in value-based care models, OCM and other APMs, and the increasing role of employers in value-based care and payment.
At the Oncology Clinical Pathways Congress, Chadi sat down with a host of experts to discuss pathway integration in value-based care models, OCM and other APMs, and the increasing role of employers in value-based care and payment.
At the Oncology Clinical...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Chadi picks the brain of Sayed Tabatabai, MD, a full-time nephrologist and avid writer that attempts to humanize and beautify the patient experience through a variety of written anecdotes in Twitter threads and short stories.
Chadi picks the brain of Sayed Tabatabai, MD, a full-time nephrologist and avid writer that attempts to humanize and beautify the patient experience through a variety of written anecdotes in Twitter threads and short stories.
Chadi picks the brain of Sayed...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Chadi makes his rounds at the Oncology Clinical Pathways Congress, catching guests and presenters such as Blase Polite, Alan Balch, and Lee Schwartzberg for some candid conversation and feedback.
Chadi makes his rounds at the Oncology Clinical Pathways Congress, catching guests and presenters such as Blase Polite, Alan Balch, and Lee Schwartzberg for some candid conversation and feedback.
Chadi makes his rounds at the...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Bobby Daly, MD, MBA, breaks down prevalent touch points in oncology clinical pathways, including conflicts of interest on pathway development panels, potential for cost variation due to site of care, and interoperability challenges between...
Bobby Daly, MD, MBA, breaks down prevalent touch points in oncology clinical pathways, including conflicts of interest on pathway development panels, potential for cost variation due to site of care, and interoperability challenges between...
Bobby Daly, MD, MBA, breaks down...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Vincent DeVita, MD, professor of medicine at Yale Cancer Center and former president of ACS, debates with Chadi some of the ideas laid out in his book, "The Death of Cancer," most notably the utility of randomized controlled trials in...
Vincent DeVita, MD, professor of medicine at Yale Cancer Center and former president of ACS, debates with Chadi some of the ideas laid out in his book, "The Death of Cancer," most notably the utility of randomized controlled trials in...
Vincent DeVita, MD, professor of...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Mark A Lewis, MD, attempts to classify the AYA patient population, explain the disconnect of clinical trial accrual in this population, and pose social media as a critical avenue for overcoming this barrier.
Mark A Lewis, MD, attempts to classify the AYA patient population, explain the disconnect of clinical trial accrual in this population, and pose social media as a critical avenue for overcoming this barrier.
Mark A Lewis, MD, attempts to...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Pat Basu, MD, MBA, president and CEO of Cancer Treatment Centers of America, shares with Chadi his unique experience of combining the clinical health care discipline with business and policy.
Pat Basu, MD, MBA, president and CEO of Cancer Treatment Centers of America, shares with Chadi his unique experience of combining the clinical health care discipline with business and policy.
Pat Basu, MD, MBA, president and...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Sekar Kathiresan, MD, sits down with Chadi to discuss his unique career path from esteemed cardiologist and physician-geneticist at Massachusetts General Hospital to co-founder and CEO of Verve Therapeutics.
Sekar Kathiresan, MD, sits down with Chadi to discuss his unique career path from esteemed cardiologist and physician-geneticist at Massachusetts General Hospital to co-founder and CEO of Verve Therapeutics.
Sekar Kathiresan, MD, sits down...
05/03/2022
Journal of Clinical Pathways
OUTSPOKEN ONCOLOGY
05/03/2022
Opinions collide in this spirited debate about how physicians can and should enter conversations on political issues as Chadi and returning guest Saurabh Jha expound on a recent Lancet article focused on the Kashmir conflict.
Opinions collide in this spirited debate about how physicians can and should enter conversations on political issues as Chadi and returning guest Saurabh Jha expound on a recent Lancet article focused on the Kashmir conflict.
Opinions collide in this...
05/03/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement